nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP2C19—urine—hypothyroidism	0.0881	0.193	CbGeAlD
Ramelteon—MTNR1A—blood—hypothyroidism	0.0876	0.191	CbGeAlD
Ramelteon—MTNR1A—testis—hypothyroidism	0.0724	0.158	CbGeAlD
Ramelteon—CYP1A2—urine—hypothyroidism	0.072	0.157	CbGeAlD
Ramelteon—CYP3A4—urine—hypothyroidism	0.0521	0.114	CbGeAlD
Ramelteon—Arthralgia—Dextrothyroxine—hypothyroidism	0.0266	0.0536	CcSEcCtD
Ramelteon—Arthralgia—Levothyroxine—hypothyroidism	0.0266	0.0536	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.0232	0.0468	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.0232	0.0468	CcSEcCtD
Ramelteon—Insomnia—Levothyroxine—hypothyroidism	0.0231	0.0465	CcSEcCtD
Ramelteon—Insomnia—Dextrothyroxine—hypothyroidism	0.0231	0.0465	CcSEcCtD
Ramelteon—Dysgeusia—Liotrix—hypothyroidism	0.0225	0.0454	CcSEcCtD
Ramelteon—Fatigue—Dextrothyroxine—hypothyroidism	0.022	0.0443	CcSEcCtD
Ramelteon—Fatigue—Levothyroxine—hypothyroidism	0.022	0.0443	CcSEcCtD
Ramelteon—Arthralgia—Liotrix—hypothyroidism	0.0196	0.0394	CcSEcCtD
Ramelteon—Anaphylactic shock—Liotrix—hypothyroidism	0.0188	0.0378	CcSEcCtD
Ramelteon—Asthenia—Dextrothyroxine—hypothyroidism	0.0183	0.0369	CcSEcCtD
Ramelteon—Asthenia—Levothyroxine—hypothyroidism	0.0183	0.0369	CcSEcCtD
Ramelteon—Diarrhoea—Levothyroxine—hypothyroidism	0.0175	0.0352	CcSEcCtD
Ramelteon—Diarrhoea—Dextrothyroxine—hypothyroidism	0.0175	0.0352	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.0171	0.0344	CcSEcCtD
Ramelteon—Insomnia—Liotrix—hypothyroidism	0.017	0.0342	CcSEcCtD
Ramelteon—CYP2C19—blood—hypothyroidism	0.0168	0.0368	CbGeAlD
Ramelteon—Fatigue—Liotrix—hypothyroidism	0.0162	0.0326	CcSEcCtD
Ramelteon—Headache—Dextrothyroxine—hypothyroidism	0.016	0.0322	CcSEcCtD
Ramelteon—Headache—Levothyroxine—hypothyroidism	0.016	0.0322	CcSEcCtD
Ramelteon—Nausea—Dextrothyroxine—hypothyroidism	0.0152	0.0305	CcSEcCtD
Ramelteon—Nausea—Levothyroxine—hypothyroidism	0.0152	0.0305	CcSEcCtD
Ramelteon—CYP1A2—blood—hypothyroidism	0.0138	0.0301	CbGeAlD
Ramelteon—Asthenia—Liotrix—hypothyroidism	0.0135	0.0271	CcSEcCtD
Ramelteon—CYP1A2—thyroid gland—hypothyroidism	0.0133	0.029	CbGeAlD
Ramelteon—CYP2C19—liver—hypothyroidism	0.0132	0.0288	CbGeAlD
Ramelteon—Diarrhoea—Liotrix—hypothyroidism	0.0128	0.0259	CcSEcCtD
Ramelteon—Dizziness—Liotrix—hypothyroidism	0.0124	0.025	CcSEcCtD
Ramelteon—Headache—Liotrix—hypothyroidism	0.0118	0.0237	CcSEcCtD
Ramelteon—Nausea—Liotrix—hypothyroidism	0.0111	0.0225	CcSEcCtD
Ramelteon—CYP1A2—liver—hypothyroidism	0.0108	0.0235	CbGeAlD
Ramelteon—CYP3A4—blood—hypothyroidism	0.00996	0.0218	CbGeAlD
Ramelteon—CYP3A4—liver—hypothyroidism	0.00779	0.017	CbGeAlD
Ramelteon—MTNR1A—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00288	0.0627	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00288	0.0627	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00146	0.0318	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00146	0.0318	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.0013	0.0283	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.0013	0.0283	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.0013	0.0283	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.0013	0.0283	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—TRH—hypothyroidism	0.00111	0.0242	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—TRH—hypothyroidism	0.00111	0.0242	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—AVP—hypothyroidism	0.00109	0.0238	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—AVP—hypothyroidism	0.00109	0.0238	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—TSHB—hypothyroidism	0.000991	0.0216	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—TSHB—hypothyroidism	0.000991	0.0216	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—TSHR—hypothyroidism	0.000991	0.0216	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—TSHR—hypothyroidism	0.000991	0.0216	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000767	0.0167	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000767	0.0167	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—POMC—hypothyroidism	0.000641	0.014	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—POMC—hypothyroidism	0.000641	0.014	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—TRH—hypothyroidism	0.000628	0.0137	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—TRH—hypothyroidism	0.000628	0.0137	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—AVP—hypothyroidism	0.000584	0.0127	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—AVP—hypothyroidism	0.000584	0.0127	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—TRH—hypothyroidism	0.000571	0.0124	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—TRH—hypothyroidism	0.000571	0.0124	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—TSHB—hypothyroidism	0.00056	0.0122	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—TSHB—hypothyroidism	0.00056	0.0122	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—TSHR—hypothyroidism	0.00056	0.0122	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—TSHR—hypothyroidism	0.00056	0.0122	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00051	0.0111	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00051	0.0111	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—TSHR—hypothyroidism	0.000509	0.0111	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—TSHB—hypothyroidism	0.000509	0.0111	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—TSHR—hypothyroidism	0.000509	0.0111	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—TSHB—hypothyroidism	0.000509	0.0111	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CLTC—hypothyroidism	0.00039	0.0085	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CLTC—hypothyroidism	0.00039	0.0085	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—POMC—hypothyroidism	0.000388	0.00845	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—POMC—hypothyroidism	0.000388	0.00845	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—VAV3—hypothyroidism	0.000343	0.00746	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—VAV3—hypothyroidism	0.000343	0.00746	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TRH—hypothyroidism	0.000337	0.00734	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TRH—hypothyroidism	0.000337	0.00734	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—AVP—hypothyroidism	0.00033	0.00719	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—AVP—hypothyroidism	0.00033	0.00719	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—VAV3—hypothyroidism	0.000311	0.00678	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—VAV3—hypothyroidism	0.000311	0.00678	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TSHB—hypothyroidism	0.0003	0.00654	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TSHB—hypothyroidism	0.0003	0.00654	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TSHR—hypothyroidism	0.0003	0.00654	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TSHR—hypothyroidism	0.0003	0.00654	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—AVP—hypothyroidism	0.0003	0.00653	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—AVP—hypothyroidism	0.0003	0.00653	CbGpPWpGaD
Ramelteon—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000279	0.00607	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SH2B3—hypothyroidism	0.000268	0.00583	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SH2B3—hypothyroidism	0.000268	0.00583	CbGpPWpGaD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000226	0.00492	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—POMC—hypothyroidism	0.000219	0.00478	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—POMC—hypothyroidism	0.000219	0.00478	CbGpPWpGaD
Ramelteon—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000217	0.00473	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—POMC—hypothyroidism	0.000199	0.00434	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—POMC—hypothyroidism	0.000199	0.00434	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PRL—hypothyroidism	0.000199	0.00433	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PRL—hypothyroidism	0.000199	0.00433	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—VAV3—hypothyroidism	0.000184	0.004	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—VAV3—hypothyroidism	0.000184	0.004	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—AVP—hypothyroidism	0.000177	0.00386	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—AVP—hypothyroidism	0.000177	0.00386	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000176	0.00383	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000167	0.00365	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—IYD—hypothyroidism	0.000142	0.00308	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000136	0.00296	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ATP5O—hypothyroidism	0.00012	0.00262	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—POMC—hypothyroidism	0.00012	0.00261	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—POMC—hypothyroidism	0.000118	0.00256	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—POMC—hypothyroidism	0.000118	0.00256	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IGF1—hypothyroidism	0.000113	0.00247	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IGF1—hypothyroidism	0.000113	0.00247	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TPO—hypothyroidism	0.000113	0.00246	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—IYD—hypothyroidism	0.00011	0.0024	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000105	0.00228	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ATP5O—hypothyroidism	9.37e-05	0.00204	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—POMC—hypothyroidism	9.35e-05	0.00204	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TPO—hypothyroidism	8.81e-05	0.00192	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—IYD—hypothyroidism	8.51e-05	0.00185	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.17e-05	0.00178	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ATP5O—hypothyroidism	7.24e-05	0.00158	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—POMC—hypothyroidism	7.21e-05	0.00157	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TPO—hypothyroidism	6.8e-05	0.00148	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TSHB—hypothyroidism	5.24e-05	0.00114	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	4.67e-05	0.00102	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.61e-05	0.001	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TSHB—hypothyroidism	4.08e-05	0.000889	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC5A5—hypothyroidism	3.92e-05	0.000854	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	3.64e-05	0.000792	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.59e-05	0.000782	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TSHB—hypothyroidism	3.15e-05	0.000686	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC5A5—hypothyroidism	3.05e-05	0.000665	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.81e-05	0.000611	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.36e-05	0.000514	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—POMC—hypothyroidism	2.05e-05	0.000447	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—POMC—hypothyroidism	1.6e-05	0.000348	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—POMC—hypothyroidism	1.23e-05	0.000269	CbGpPWpGaD
